Molecular mechanisms underlying p62-dependent secretion of the Alzheimer-associated ubiquitin variant UBB(+1)

阿尔茨海默病相关泛素变体UBB(+1)的p62依赖性分泌的分子机制

阅读:3

Abstract

UBB(+1), a ubiquitin variant protein resulting from a frameshift in the ubiquitin-B gene, is a pathological hallmark of Alzheimer disease (AD). At the cellular level, UBB(+1) disrupts the ubiquitin-proteasome system while inducing autophagy. Notably, UBB(+1) itself is secreted via autophagosome-like vesicles. Here, we demonstrate that UBB(+1) can be removed from the cell by degradative and secretory autophagy. Sequestosome 1 (SQSTM1)/p62 functions as a pivotal ubiquitin receptor for UBB(+1), recognizing its ubiquitin domain and facilitating loading into autophagosomes. Oligomerization of SQSTM1/p62 was critical to isolate UBB(+1) in bodies preventing its aggregation. Intriguingly, both gain- and loss-of-function SQSTM1/p62 suppressed UBB(+1) secretion, causing intracellular retention: SQSTM1/p62 knockout led to UBB(+1) accumulation in insoluble aggregates, while its overexpression promoted the formation of p62-UBB(+1) bodies. We further identified distinct roles for SNARE-mediated membrane fusion in secretory autophagy of UBB(+1). Specifically, the R-SNARE SEC22B and the Q-SNAREs Syntaxin-4 and SNAP23 participated in UBB(+1) exocytosis. Disruption of SEC22B impaired the fusion of UBB(+1)-containing autophagosomes with the plasma membrane, reducing UBB(+1) secretion without affecting its intracellular turnover. Inhibition of lysosomes partially stabilized UBB(+1) indicating that degradation and secretion are complementary processes that determine the fate of UBB(+1). This study elucidates the dual roles of autophagy in managing neurotoxic proteins, highlighting SQSTM1/p62 as a key mediator of UBB(+1) trafficking and secretion. Although ubiquitin typically acts as a degradation signal, our findings reveal a rare instance of a ubiquitin-related protein driving secretory autophagy. These findings advance our understanding of cellular mechanisms underlying the clearance of misfolded proteins in neurodegenerative diseases.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。